A Pragmatic Framework for Shared Decision Making in Older Adults: Cardiac Amyloidosis as a Prototype

Monika Do1, Sandesh Dev2, Pranav Pillai3

  • 1US Department of Veteran's Affairs, Nashville, Tennessee, USA.

Insights

Managing transthyretin cardiac amyloidosis (ATTR-CA) in older adults is complex. A new framework using comprehensive geriatric assessment (CGA) and shared decision-making (SDM) personalizes care for these patients.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Amyloidosis Research

Background:

  • Advanced chronic diseases in older adults, like transthyretin cardiac amyloidosis (ATTR-CA), present significant management challenges, often with heart failure as a primary symptom.
  • Diagnosing and treating ATTR-CA in the elderly population requires careful consideration of unique patient factors and treatment implications.

Purpose of the Study:

  • To describe the diagnostic and management challenges of ATTR-CA in older adults.
  • To propose an innovative framework integrating comprehensive geriatric assessment (CGA) and shared decision-making (SDM) for patient-centered care in ATTR-CA.
  • To adapt this framework for broader application in complex chronic diseases.

Main Methods:

  • Application of geriatric medicine principles to develop a framework for SDM.
  • Emphasis on assessing patient functionality, frailty, and life expectancy for risk categorization.
  • Development of management pathways based on risk, treatment burden, and patient values.

Main Results:

  • The proposed framework facilitates tailored clinical recommendations by considering individual patient needs, goals, and preferences.
  • Risk stratification based on CGA and SDM aids in defining appropriate management strategies for ATTR-CA patients.
  • Collaboration between cardiology and geriatric medicine enhances care for older adults with ATTR-CA.

Conclusions:

  • The integrated framework supports holistic, patient-centered care for older adults with ATTR-CA and other complex chronic conditions.
  • This approach helps prevent age-related bias in clinical decision-making by evaluating multimorbidity, frailty, and patient preferences.
  • Implementing CGA and SDM is essential for aligning treatment plans with patient values and improving overall care delivery.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248